Overview

A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder

Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
The primary aim of the present study is to examine the efficacy and safety of tolcapone in adults with moderate to severe OCD.
Phase:
Phase 2
Details
Lead Sponsor:
University of Chicago
Treatments:
Tolcapone